WYATT SCHMIDT: Open Payments
NPI 1215281282 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 17 payments from 10 companies in 2025. Trend: 2023 $131 · 2024 $199 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $14 |
Products named: TRINTELLIX, MOUNJARO, UBRELVY, SPRAVATO, FUROSCIX, Wegovy, Veozah, NUZYRA.
Industry payments across IA — which companies pay providers there.
